Shares of Indivior PLC (LON:INDV – Get Free Report) were up 1.6% during mid-day trading on Wednesday. The company traded as high as GBX 1,264 and last traded at GBX 1,238. Approximately 8,457,898 shares changed hands during mid-day trading, an increase of 959% from the average session volume of 798,658 shares. The stock had previously closed at GBX 1,219.
Indivior Stock Up 1.6%
The business’s fifty day moving average price is GBX 1,238 and its 200 day moving average price is GBX 1,238. The company has a market capitalization of £1.93 billion, a P/E ratio of -1,026.48, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a current ratio of 0.89, a quick ratio of 1.52 and a debt-to-equity ratio of -107.76.
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder.
See Also
- Five stocks we like better than Indivior
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
